Background A periodic electrical activity, termed ''slow waves'', coordinates gastrointestinal contractions. Slowwave dysrhythmias are thought to contribute to dysmotility syndromes such as postoperative gastroparesis, but the clinical significance of these dysrhythmias remains poorly defined. Electrogastrography (EGG) has been unable to characterize dsyrhythmic activity reliably, and the most accurate method for evaluating slow waves is to record directly from the surface of the target organ. This study presents a novel laparoscopic device for recording serosal slow-wave activity, together with its validation. Methods The novel device consists of a shaft (diameter, 4 mm; length, 300 mm) and a flexible connecting cable. It contains four individual electrodes and is fully shielded.
curvature and travel to the antrum at a normal frequency of approximately 3 cycles per minute (cpm) [2] . Slow-wave dysrhythmias are thought to play an important role in a number of dysmotility syndromes, such as gastroparesis and functional dyspepsia [3] [4] [5] , and also may play an important role in the acute or chronic delayed gastric emptying seen after various types of GI surgery [6] .
To date, the major tool for investigating the nature and significance of slow-wave dysrhythmias clinically has been electrogastrography (EGG), which involves placing cutaneous electrodes over the abdomen in a manner analogous to electrocardiography (ECG). A noninvasive approach, EGG can provide basic information on the frequency, rhythmicity, and amplitude of slow-wave activity [7] . However, EGG as currently practiced cannot reliably define the spatiotemporal properties of slow-wave activation such as the direction and velocity of propagation, details required for accurate description of both normal and abnormal slow-wave activity [8, 9] .
For recording the spatiotemporal properties of slowwave activation reliably, it currently is necessary to record the electrical potentials directly from the surface of the target organ [2] . To date, only a relatively small number of such recordings have been performed in clinical studies. As a result, the clinical significance of slow-wave dysrhythmias remains poorly defined [8] .
The adoption of minimally invasive techniques for the treatment of gastrointestinal disease has been striking. Laparoscopic techniques offer a minimally invasive way to record electrical activity directly from the serosal surface of the GI tract, but this has rarely been attempted or validated. In this study, we present the design and validation of a novel device for laparoscopically recording high-quality slow-wave activity.
Materials and methods

Design and fabrication
The novel laparoscopic device consists of a shaft (diameter, 4 mm; length, 300 mm) containing a 2 9 2 array of electrodes at its recording tip and a flexible connecting cable (length, 1.7 m). The device was designed for atraumatic placement on the GI serosal surface without the need for electrode penetration into the seromuscular layer or for clipping or suturing of the electrodes into a fixed position.
The design of the device is demonstrated in Fig. 1 .The four electrodes were fabricated from Teflon-coated silver wires with a diameter of 0.3 mm. The choice of this electrode size was based on previous experience regarding the optimal size for slow-wave recording [10] . The interelectrode distance was limited to approximately 2 mm to allow the complete device to fit through a 5-mm surgical trocar. The electrode wires were soldered individually to Teflon-coated stainless steel connecting wires, and together these were sheathed in a heat-shrink tube. A stainless steel shield was pulled over the shrink tubing, and the whole bundle was inserted into a larger-diameter (4 mm) Teflon tube. The Teflon tube then was filled with enough epoxy resin to fill the contained space and make the shaft stiff enough to allow straightforward direction of the electrodes toward the target organ through a laparoscopic trocar.
At the end of the shaft, the connecting wires were run through a flexible connecting cable of adequate length (1.7 m) to allow positioning of the recording equipment clear of the sterile operating field. This cable was fabricated from a sheath of 6-mm silicone tubing, which was placed over stainless steel shielding in continuity with that of the shaft. At the end of the cable, the connecting wires were connected to a bayonet jack and socket connector set designed to connect with the slow-wave acquisition device, as described in the next section.
Methods of the porcine in vivo validation trial
Validation of the device was performed with a porcine model by comparing gastric slow-wave recordings from the novel laparoscopic device with those from a 32-channel (4 9 8) epoxy-resin platform (E32).The E32 is a standard rigid multielectrode platform similar to those used in many previous studies involving the serosal mapping of slowwave activity, and was custom built in our laboratory [8] [9] [10] . Both the novel device and the E32 platform were connected via a 1.5-m 68-way ribbon cable to an ActiveTwo signal acquisition system (Biosemi, Amsterdam, The Netherlands). The ActiveTwo is a direct current (DC) amplifier performing 24-bit sampling at 31-nV resolution through as many as 256 electrode channels.
Unipolar recordings were taken with a reference electrode positioned on the lower abdomen. The ActiveTwo system was in turn connected to a notebook computer via a fiber-optic cable. This setup allows the acquisition system, which runs on battery power, to be electrically decoupled from the external current source. The acquisition software was written in Labview 8.2 (National Instruments, Texas, USA).The recording frequency was set at 512 Hz. The onscreen display signals were filtered by a low-pass filter with a cutoff frequency of 10 Hz.
After each recording, signals were filtered, slow waves characterized, and activation times mapped according to our previously described methods [9, 11] . Recorded noise was quantified by the amplitude of the highest frequency component in a power spectrum of a representative 20-s recording window, and the signal-to-noise ratio (SNR) was expressed in decibels (dB).
Ethical approval for validation was obtained from the local institutional committee (the University of Auckland Animal Ethics Committee), and the International Guiding Principles for Biomedical Research Involving Animals were followed. Validation was performed with two female weaner cross-breed pigs weighing, respectively, 37.6 and 33.4 kg. Induction anesthesia was achieved with tiletamine HCl 50 mg/ml and zolazepam HCl 50 mg/ml, followed by intubation and maintenance anesthesia with isoflurane.
The pigs were placed supine on a heating pad, with continuous monitoring undertaken to ensure that arterial blood pressure, temperature, and oxygen saturations were maintained within normal physiologic ranges. A bilateral subcostal laparotomy incision was performed and the anterior gastric serosal surface exposed. The E32 platform and laparoscopic device were positioned on the gastric corpus of each pig, separated by a 45-mm gap, in the positions shown in Fig. 2A . The electrode positions were the same for both pigs. The platforms were secured into position with test tube clamps. The wound edges were approximated as much as possible, and a 10-min period of stabilization was allowed before a 15-min recording period.
Slow-wave amplitudes were statistically compared over 20 consecutive representative slow-wave events from each pig in the laparoscopic device and E32 platform recording channels using Student's t-test. A p value less than 0.05 was considered significant for a difference in recording amplitudes between the platforms.
Methods for the human intraoperative validation trial
After validation with the porcine model, an additional trial was conducted with a separate prototype for additional validation of the device in the human intraoperative environment. Ethical approval was obtained from the New Zealand Northern X Regional Human Ethics Committee. Informed consent for participation was obtained from a 28-year-old woman undergoing a routine laparoscopic cholecystectomy for mild acute cholecystitis. This patient had no significant additional medical history, had no personal or family history of gastric symptoms or diseases, and was receiving only intravenous antibiotics and analgesia.
After routine anesthesia, abdominal insufflation, and laparoscopic trocar placement for cholecystectomy, but before commencement of further dissection, the novel laparoscopic device was inserted via a 10-mm epigastric port under direct vision. The device tip was placed on the serosal surface of the mid antrum (Fig. 3A) . The device was handheld, with the recording hand held steady against the anterior abdominal wall and the trocar itself. The recording setup was otherwise as described earlier. A 10-min period of recording was obtained, and the quality of the recorded signals was assessed at the completion of the experiment by determining the frequency, amplitude, and velocity of slow-wave events and the SNR.
Results
Porcine in vivo validation trial
Slow-wave activity was immediately and continuously recorded via both the novel laparoscopic device and the standard E32 platform in the two porcine trials. A typical 80-s recording window is shown in Fig. 2B comparing slow-wave events from three laparoscopic device channels and three E32 channels. Clean, high-quality signals are demonstrated in both recordings. Regular slow-wave activity was recorded in all channels at 2.35 ± 0.05 cycles per minute (cpm) in the first trial and 2.37 ± 0.21 cpm in the second trial. Figure 2B also demonstrates a time lag of approximately 6.5 s in the registration of slow-wave events between the E32 platform and the laparoscopic device. Because the two types of electrode platforms were placed 45 mm apart, this time lag implies that the velocity of the slow waves was approximately 6.9 mm/s between the two platforms. This velocity is within the anticipated range for the porcine corpus [9] . This anticipated lag confirms that the recorded events were true slow-wave activity and not extraneous noise such as movement artifacts, which would register in all channels simultaneously.
Slow-wave amplitudes were found to be comparable between the laparoscopic device and the E32 platform. In the first trial, the recorded amplitudes were 0.38 ± 0.02 mV in the laparoscopic device and 0.36 ± 0.01 mV in the E32 platform (p = 0.45), and in the second trial, they were 0.38 ± 0.03 mV in the laparoscopic device and 0.38 ± 0.03 mV in the E32 (p = 0.94). The SNR was comparable between the laparoscopic device (13.7 dB) and the E32 platform (12.6 dB) for the evaluated period.
Human intraoperative validation trial
The novel laparoscopic device was easily inserted through the surgical trocar (Fig. 3A) . Slow-wave activity was immediately and continuously recorded by the device in contact with the gastric antrum and found to be regular at 3.1 ± 0.2 cpm for the duration of the recording. The slowwave amplitude over 10 consecutive cycles was 0.41 ± 0.04 mV, with an SNR (12.6 dB) similar to that noted in the in vivo porcine validation study. A typical slow-wave event from the intraoperative trial is shown in Fig. 3B . A small lag may be identified between the device's individual recording channels, again serving to confirm that the recorded event represents true slow-wave activity and not extraneous noise, which would register in all channels simultaneously.
The slow-wave activation times for each of the device's four individual electrodes were calculated from the event demonstrated in Fig. 3B . Figure 3C displays these activation times, together with an activation map constructed by interpolation over a projection of the laparoscopic device's recording tip. This activation map demonstrates normal aboral slow-wave propagation at a velocity of 6.3 ± 0.9 mm/s.
Discussion
This report details the design of a novel laparoscopic device for recording gastrointestinal slow-wave activity. Validation of this device was achieved in an in vivo porcine trial, with recordings found to be on par with those of a standard multielectrode platform of the type used in many previous serosal slow-wave mapping studies. The device was successfully tested during a human intraoperative trial, in which it was also found to achieve high-quality slowwave recordings with a good SNR.
The novel device incorporates a number of important design features that make it a valuable and practical research tool. The recording head contains four separate electrodes. This duplication translates to a stronger assurance of achieving a quality recording in one or more channels if the other channels are affected by signal artifact or poor contact. The comprehensive stainless steel shielding is shown to minimize signal interference successfully, resulting in the excellent SNR. A major strength of the device is ease of use. It is readily deployed through a 5-or 10-mm trocar and handheld in the desired position against the serosa, without the need for technically demanding manipulations such as suture fixation or external devices or retractor arms to support it.
Although the device has a small intraelectrode distance, this distance is large enough to discern an appreciable time lag in the detection of activities between the individual channels. This time lag eliminates the possibility of confusing slow-wave events with signal noise, such as respiration or movement artifacts, which would occur in all channels simultaneously. This time lag also allows determination of the slow-wave activation sequence across the device's recording tip, as demonstrated during the human trial in this study (Fig. 3C) . The estimation of the slowwave velocity by this method has a relatively large error due to the close proximity of the electrodes. However, the activation sequence provides useful spatiotemporal knowledge regarding the direction and velocity of slowwave propagation at the point of measurement.
To our knowledge, only one technique of recording slow waves via a laparoscopic approach has been described previously [12] . With that technique, two stainless steel cardiac pacing wires were inserted into the seromuscular layers of the gastric antrum and small bowel.
The novel device described in this report offers a number of advantages over the pacing wire method including the increased number of electrodes, effective shielding, high signal quality, ease of use, and the extra spatiotemporal detail conveyed. Our novel device also is atraumatic, eliminating the risk of peritoneal contamination with GI contents from the puncture sites created during insertion of penetrating wires.
Recordings of slow-wave activity are considered stable to the influence of anesthesia on the basis of previous studies, and the described device is therefore expected to achieve reliable interoperative recordings [13] [14] [15] . However, slowwave dysrhythmias have been characterized previously under the influence of opiates, including fentanyl, and recordings should therefore be interpreted with an awareness for confounding effects when opiates are in use [8] .
The described device provides another method for recording slow-wave activity. No current method is ideal because all represent a compromise between invasiveness, spatiotemporal detail, and recording quality. The noninvasive technique of EGG has been the most widely used method, but EGG as currently practiced cannot provide the spatiotemporal detail necessary to quantify the direction and velocity of slow-wave propagation or to discriminate reliably between normal and abnormal activity. For these reasons, EGG does not correlate strongly with symptoms or clinical markers of dysmotility and remains of limited diagnostic and research value [16, 17] .
A more recently developed noninvasive method for recording slow-wave activity is magnetogastrography, which records the magnetic field accompanying slow-wave propagation via the use of a superconducting quantum interference device (SQUID) [18] . However, the SQUID is an expensive and specialized tool currently available only to a small number of researchers, and magnetogastrography continues to be an experimental technique [2] .
The most accurate method for recording the detailed spatiotemporal properties of slow-wave activation is by high-resolution mapping. High-resolution mapping involves placing a grid of recording electrodes (typically [100) over the serosal surface of target organs, ensuring precise knowledge concerning the sequence of electrical activation over an organ surface [8, 9] . Although ideal, this technique requires an open abdomen and therefore is applicable only to operations requiring a large incision. Recordings can be achieved via a less invasive approach at the mucosal surface (e.g., by hemoclipping or suctioning electrodes into position) [19, 20] . Although sparse detail regarding slow-wave propagation direction and velocity can be gained via these mucosal recording techniques, the high electrical impedence of the mucosa significantly reduces the signal quality of recordings, and the mucosal electrodes are prone to dislodging [20] .
Similar to the mucosal recording methods, our novel laparoscopic device can record GI electrical activity only in sparse spatiotemporal detail. However, as shown in this study, it does allow construction of a small activation map, and two or more of the devices also can be used simultaneously, placed in a succession of positions, to generate a more detailed evaluation of electrical activation.
It is likely that the laparoscopic approach would be considered too invasive for the routine investigation of dysmotility disorders in humans, although it might prove useful in severe cases. However, the novel device does open up the opportunity to investigate and define normal and altered electrical activity in patients undergoing routine laparoscopic surgery.
It is known that gastric incisions can significantly alter the frequency, rhythm, and propagation patterns of slowwave activity in the stomach [21] . Although a number of routine operations irreversibly alter the anatomy of significant portions of the gastric conduction system, the myoelectrical effects of these procedures have not yet been adequately documented or used to predict functional outcome. In particular, only a very few studies to date have evaluated whether altered electrophysiology is a factor contributing significantly to the acute or chronic delays in gastric emptying seen after operations such as fundoplication for gastroesophageal reflux, proximal gastrectomy for cancer, pancreatocoduodenectomy, sleeve gastrectomy, and gastric bypass surgery for morbid obesity [6, 22, 23] .
We anticipate that the new laparoscopic device and high-resolution mapping tools suited to open surgery [9] will be used to compare slow-wave activity before and after surgical manipulations in these and other operations to define the precise electrophysiologic consequences of the surgery. Correlations between the slow-wave outcomes measured (frequency, rhythm, amplitude, direction, and velocity of propagation) and the patients' dysmotility and symptom indices will thereafter allow a clear determination of the role that electrical disturbances play in postoperative dysmotility.
In addition, a recent study has described the complex events underlying gastric dysrhythmias for the first time, showing complex focal activities and reentrant patterns similar to pathologic electrical activities well known to occur in the heart [8] . The presence, prevalence, and effect of these complex dysrhythmic behaviors in clinical and postoperative dysmotility disorders need to be determined, and this novel laparoscopic device should provide a useful investigative tool, at least for severe cases. Gastric electrical stimulation (GES) has been proposed previously as a potential means for treating gastric dysrhythmias and dysmotility problems of patients, including postsurgical patients [24] . This device may therefore also assist in clarifying whether a real potential benefit can be gained from using GES to manipulate slow-wave behavior to enhance recovery after surgery and to help in the development of clinically effective GES devices for human use.
Because this tool is limited to the intraoperative setting, it also would be of future value if an implantable device were developed to allow chronic recordings in selected patients. Prototype implant devices have been developed previously and tested in animal models, but further work is needed before such devices are deemed suitable for human use [25] .
In conclusion, the novel laparoscopic device presented in this report, together with its in vivo validation, will provide new opportunities for recording slow-wave activity during surgery. The device will be a valuable tool for facilitating new clinical studies of normal and dsyrhythmic slow-wave activity. In particular, it will help to define the effects of various GI surgical procedures on slow-wave activity.
